Frank Cullen, The Dallas Morning News; The Biden administration is endangering intellectual property rights
"Simply put, the waiver seeks to solve a problem that doesn’t exist.
What the waiver would do is quash the development of additional COVID-19 countermeasures, from lifesaving antiviral pills to rapid tests even more accurate than the ones we have. Firms currently investing in new COVID-19 tests and treatments will have no reason to continue their work if the IP rights for those products are preemptively nullified.
In the long term, an IP waiver would set a devastating precedent for U.S. innovators working to address crises far beyond COVID-19. Startups and inventors need secure intellectual property rights to raise funding and recoup their steep research and development costs, especially in America’s life sciences industry. New drugs often cost more than $2 billion and can take more than a decade to make it to market."
No comments:
Post a Comment